Potential antiviral role of p53 in HCV-infected patients

被引：0
|
作者：
Hamdi, N. [1 ]
El-Serafy, M. [2 ]
Esmat, G. [2 ]
Alaakel, W. [2 ]
Abdelaziz, A. I. [1 ]
机构：
[1] German Univ Cairo, Cairo, Egypt
[2] Cairo Univ, Cairo, Egypt
来源：
FEBS JOURNAL | 2009年 / 276卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [11] Adherence to therapy: Challenges in HCV-infected patients
    Pozza R.
    Barakat F.
    Current Hepatitis Reports, 2007, 6 (4) : 160 - 168
  • [12] P-BODY FORMATION IS IMPAIRED IN LIVERS FROM HCV-INFECTED PATIENTS
    Fernandez-Carrillo, C.
    Perez-Vilaro, G.
    Mensa, L.
    Perez-del-Pulgar, S.
    Forns, X.
    Diez, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S141 - S141
  • [13] ROLE OF FAS ANTIGEN EXPRESSION IN HCV-INFECTED LIVER
    HIRAMATSU, N
    HAYASHI, N
    KATAYAMA, K
    MOCHIZUKI, K
    KAWANISHI, Y
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    HEPATOLOGY, 1994, 19 (04) : I73 - I73
  • [14] The role of p53 in regulating antiviral T cell responses
    Grayson, JM
    Lanier, JG
    Altman, JD
    Ahmed, R
    JOURNAL OF IMMUNOLOGY, 2001, 167 (03): : 1333 - 1337
  • [15] Similar Progression of Fibrosis Between HIV/HCV-Infected and HCV-Infected Patients: Analysis of Paired Liver Biopsy Samples
    Sterling, Richard K.
    Wegelin, Jacob A.
    Smith, Paula G.
    Stravitz, R. Todd
    Luketic, Velimir A.
    Fuchs, Michael
    Puri, Puneet
    Shiffman, Mitchell L.
    Contos, Melissa A.
    Mills, A. Scott
    Sanyal, Arun J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (12) : 1070 - 1076
  • [16] RAPID AND SUSTAINED IMPROVEMENTS OF LIVER STIFFNESS VALUES IN HCV-INFECTED PATIENTS TREATED WITH DIRECT ANTIVIRAL DRUGS
    Attia, D.
    Deterding, K.
    Cornberg, J.
    Manns, M.
    Gebel, M.
    Cornberg, M.
    Wedemeyer, H.
    Potthoff, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S720 - S720
  • [17] Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
    Stevenson H.L.
    Utay N.S.
    Tropical Diseases, Travel Medicine and Vaccines, 2 (1)
  • [18] Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients
    Lorenzini, Kuntheavy Ing
    Girardin, Francois
    LIVER INTERNATIONAL, 2020, 40 (01) : 32 - 44
  • [19] Impact of all-oral antiviral therapy on portal pressure and hemodynamics on HCV-infected cirrhotic patients
    Lens, Sabela
    Alvarado-Tapias, Edilmar
    Marino, Zoe
    Londono, Maria-Carlota
    Llop, Elba
    Gonzalez, Javier M.
    Ignacio Fortea, Jose
    Ibanez Samaniego, Luis
    Banares, Rafael
    Puente, Angela
    Albillos, Agustin
    Calleja, Jose L.
    Torras, Xavier
    Hernandez-Gea, Virginia
    Bosch, Jaime
    Villanueva, Candid
    Forns, Xavier
    Carlos Garcia-Pagan, Juan
    HEPATOLOGY, 2016, 64 : 30A - 31A
  • [20] Detection of HCV-RNA in cerumen of chronically HCV-infected patients
    Bayindir, Y
    Kalcioglu, T
    Durmaz, R
    Ozturan, O
    LARYNGOSCOPE, 2005, 115 (03): : 508 - 511
12345